1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Blood Loss, Surgical in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Møller, CH; Steinbrüchel, DA | 1 |
| Arnoux, B; Cornu, E; Denizot, Y; Feiss, P; Laskar, M; Mercury, P; Nathan, N | 1 |
| Despotis, GJ; Filos, KS; Goodnough, LT; Joist, JH; Levine, V; Santoro, SA; Spitznagel, E | 1 |
| Ereth, MH; Harmsen, WS; Klindworth, JT; MacVeigh, I; Nuttall, GA; Oliver, WC; Orszulak, TA; Santrach, PJ | 1 |
| Ereth, MH; Klindworth, JT; Nuttall, GA; Oliver, WC; Santrach, PJ; Schaff, HV | 1 |
2 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Blood Loss, Surgical
| Article | Year |
|---|---|
Effects of the platelet-activating factor receptor antagonist BN 52021 on hematologic variables and blood loss during and after cardiopulmonary bypass.
Topics: Analysis of Variance; Blood Loss, Surgical; Blood Platelets; Cardiopulmonary Bypass; Diterpenes; Double-Blind Method; Female; Ginkgolides; Humans; Infusions, Intravenous; Lactones; Leukocyte Count; Leukocytes; Male; Middle Aged; Platelet Activating Factor; Platelet Count | 1994 |
The relation between the platelet-activated clotting test (HemoSTATUS) and blood loss after cardiopulmonary bypass.
Topics: Aged; Blood Coagulation Tests; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Critical Care; Female; Humans; Male; Middle Aged; Platelet Activating Factor; Platelet Count; Predictive Value of Tests; Statistics, Nonparametric | 1998 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Blood Loss, Surgical
| Article | Year |
|---|---|
Platelet function after coronary artery bypass grafting: is there a procoagulant activity after off-pump compared with on-pump surgery?
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation; Blood Loss, Surgical; Blood Platelets; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Artery Disease; Female; Follow-Up Studies; Hemostasis; Humans; Male; Middle Aged; Perioperative Care; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Probability; Prospective Studies; Risk Assessment; Statistics, Nonparametric; Survival Rate; Treatment Outcome | 2003 |
Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients.
Topics: Aged; Blood Loss, Surgical; Cardiac Surgical Procedures; Deamino Arginine Vasopressin; Evaluation Studies as Topic; Female; Hemostasis; Humans; Male; Middle Aged; Platelet Activating Factor; Platelet Transfusion; Postoperative Complications; Preoperative Care; Renal Agents; Whole Blood Coagulation Time | 1996 |
Does the platelet-activated clotting test (HemoSTATUS) predict blood loss and platelet dysfunction associated with cardiopulmonary bypass?
Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Blood Loss, Surgical; Blood Platelets; Cardiopulmonary Bypass; Coronary Artery Bypass; Female; Forecasting; Heart Defects, Congenital; Heart Valves; Heparin Antagonists; Humans; Male; Mediastinum; Partial Thromboplastin Time; Platelet Activating Factor; Platelet Activation; Platelet Count; Point-of-Care Systems; Postoperative Hemorrhage; Protamines; Prothrombin Time; Reoperation; Retrospective Studies; Sensitivity and Specificity; Thrombelastography | 1997 |